Literature DB >> 15286264

Procalcitonin: a marker of severity of acute pyelonephritis among children.

Paolo Pecile1, Elisabetta Miorin, Carla Romanello, Edmondo Falleti, Francesca Valent, Francesco Giacomuzzi, Alfred Tenore.   

Abstract

OBJECTIVE: Febrile urinary tract infection (UTI) is a common problem among children. The diagnosis and management of acute pyelonephritis is a challenge, particularly during infancy. The distinction between acute pyelonephritis and UTI without renal involvement is very important, because renal infection may cause parenchymal scarring and thus requires more aggressive investigation and follow-up monitoring. However, this distinction is not easy among children, because common clinical findings and laboratory parameters are nonspecific, especially among young children. In an attempt to differentiate acute pyelonephritis from febrile UTI without renal lesions in a group of 100 children, we measured serum levels of procalcitonin (PCT), a new marker of infection. The objective of the study was to determine the accuracy of PCT measurements, compared with C-reactive protein (CRP) measurements, in diagnosing acute renal involvement during febrile UTI and in predicting subsequent scars, as assessed with 99mTc-dimercaptosuccinic acid (DMSA) scintigraphy.
DESIGN: Serum CRP levels, erythrocyte sedimentation rates, leukocyte counts, and PCT levels were measured for 100 children, 1 month to 13 years of age, admitted for suspected febrile UTI (first episode). Renal parenchymal involvement was evaluated with DMSA scintigraphy within 5 days after admission. The DMSA study was repeated 6 months later if the initial results were abnormal.
RESULTS: The mean PCT level was significantly higher in acute pyelonephritis than in UTI without renal lesions (4.48 +/- 5.84 ng/mL vs 0.44 +/- 0.30 ng/mL). In these 2 groups, the mean CRP levels were 106 +/- 68.8 mg/L and 36.4 +/- 26 mg/L, mean erythrocyte sedimentation rates were 79.1 +/- 33 mm/hour and 58.5 +/- 33 mm/hour, and leukocyte counts were 18 492 +/- 6839 cells/mm3 and 16 741 +/- 5302 cells/mm3, respectively. For the prediction of acute pyelonephritis, the sensitivity and specificity of PCT measurements were 83.3% and 93.6%, respectively; CRP measurements had a sensitivity of 94.4% but a specificity of only 31.9%. Positive and negative predictive values for prediction of renal involvement with PCT measurements were 93.7% and 83% and those with CRP measurements were 61.4% and 83.3%, respectively. When inflammatory markers were correlated with the severity of the renal lesions, as assessed with DMSA scintigraphy, a highly significant correlation with both PCT and CRP levels was found. However, when the 2 parameters were correlated with renal scarring in follow-up scans, a significant positive association was found only for PCT levels.
CONCLUSIONS: Serum PCT levels may be a sensitive and specific measure for early diagnosis of acute pyelonephritis and determination of the severity of renal parenchymal involvement. Therefore, this measurement could be useful for the treatment of children with febrile UTIs, allowing prediction of patients at risk of permanent parenchymal renal lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286264     DOI: 10.1542/peds.114.2.e249

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  35 in total

1.  Is procalcitonin a good marker of renal lesion in febrile urinary tract infection?

Authors:  David Tuerlinckx; Thierry Vander Borght; Youri Glupczynski; Laurence Galanti; Véronique Roelants; Bruno Krug; Georges de Bilderling; Eddy Bodart
Journal:  Eur J Pediatr       Date:  2005-07-16       Impact factor: 3.183

2.  The rapidly expanding role of procalcitonin as a diagnostic and prognostic assay besides in UTIs.

Authors:  Shailendra Kapoor
Journal:  Int Urol Nephrol       Date:  2009-01-08       Impact factor: 2.370

3.  Plasma neutrophil gelatinase-associated lipocalin: a marker of acute pyelonephritis in children.

Authors:  Byung Kwan Kim; Hyung Eun Yim; Kee Hwan Yoo
Journal:  Pediatr Nephrol       Date:  2016-10-15       Impact factor: 3.714

4.  Diagnostic significance of clinical and laboratory findings to localize site of urinary infection.

Authors:  Eduardo H Garin; Fernando Olavarria; Carlos Araya; Monica Broussain; Claudia Barrera; Linda Young
Journal:  Pediatr Nephrol       Date:  2007-03-21       Impact factor: 3.714

Review 5.  Diagnostic value of serum procalcitonin for acute pyelonephritis in infants and children with urinary tract infections: an updated meta-analysis.

Authors:  Huhai Zhang; Jurong Yang; Lirong Lin; Bengang Huo; Huanzi Dai; Yani He
Journal:  World J Urol       Date:  2015-07-04       Impact factor: 4.226

6.  Decreased concentrating capacity in children with febrile urinary tract infection and normal 99mTc-dimercaptosuccinic acid scan: does medullonephritis exist?

Authors:  Víctor García-Nieto; Silvia González-Cerrato; María Isabel Luis-Yanes; Margarita Monge-Zamorano; Beatriz Reyes-Millán
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

7.  Novel biomarkers for the diagnosis of urinary tract infection-a systematic review.

Authors:  Neha Nanda; Manisha Juthani-Mehta
Journal:  Biomark Insights       Date:  2009-08-05

8.  Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial.

Authors:  Sabine Faesch; Bogdan Cojocaru; Carole Hennequin; Stéphanie Pannier; Christophe Glorion; Bernard Lacour; Gérard Chéron
Journal:  Ital J Pediatr       Date:  2009-11-04       Impact factor: 2.638

9.  Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis.

Authors:  Zhina Sadeghi; Abdol-Mohammad Kajbafzadeh; Parvin Tajik; Maryam Monajemzadeh; Seyedmehdi Payabvash; Azadeh Elmi
Journal:  Pediatr Nephrol       Date:  2008-06-04       Impact factor: 3.714

10.  Low levels of procalcitonin during episodes of necrotizing enterocolitis.

Authors:  Dan Turner; Cathy Hammerman; Bernard Rudensky; Yechiel Schlesinger; Eytan Wine; Aleixo Muise; Michael S Schimmel
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.